These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4391861)

  • 1. Effect of different beta-adrenergic receptor blocking agents on hexobarbital induced narcosis in mice.
    Hermansen K
    Acta Pharmacol Toxicol (Copenh); 1969; 27(6):453-60. PubMed ID: 4391861
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prolonging hexabarbiturate anesthesia by beta adrenolytic drugs].
    Wagner J; Kierfeld E
    Arzneimittelforschung; 1971 Mar; 21(3):414-6. PubMed ID: 4396292
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of 1-(o-cyclopropylphenoxy)-3-isopropylamino-2-propanol, a new -adrenergic blocking drug.
    Boissier JR; Giudicelli JF; Viars P; Advenier C; Mouille P; Larno S
    Eur J Pharmacol; 1971 Jul; 15(2):151-9. PubMed ID: 4403548
    [No Abstract]   [Full Text] [Related]  

  • 4. Modification of hexobarbitone sodium-induced hynosis in mice by beta adrenergic receptor blocking agents.
    Singh KP
    Indian J Physiol Pharmacol; 1979; 23(1):52-4. PubMed ID: 35466
    [No Abstract]   [Full Text] [Related]  

  • 5. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

  • 6. [ adrenergic blocking agents and amphetamine or apomorphine induced stereotyped behavior in rats].
    Simon P; Chermat R; Fosset MT; Boissier JR
    Psychopharmacologia; 1972; 23(4):357-64. PubMed ID: 4402045
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible mechanism (s) of alprenolol (beta adrenergic receptor blocking agent) prolongation of pentobarbital hypnosis in mice.
    Peters MA
    J Pharmacol Exp Ther; 1972 Jun; 181(3):417-24. PubMed ID: 4402372
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of tests of adrenergic beta-receptor blockade in man and their application to a comparison of the beta-blocking potency of propranolol and oxprenolol.
    Taylor SH; Majid PA; Sharma B
    Postgrad Med J; 1970 Nov; ():Suppl:57-60. PubMed ID: 4395459
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect upon myocardial blood-flow in man of beta-blocking agents, isosorbide dinitrate, dipyridamole and their combination.
    Reale A; Nigri A; Gioffré PA; Motolese M
    Postgrad Med J; 1970 Nov; ():Suppl:60-6. PubMed ID: 4395461
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of hexobarbitone, ether, morphine, and urethane upon the acute toxicity of propranolol and D-(--)-INPEA.
    Murmann W; Almirante L; Saccani-Guelfi M
    J Pharm Pharmacol; 1966 Oct; 18(10):692-4. PubMed ID: 4382081
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of some beta adrenergic blocking agents on the central and peripheral actions of tremorine and oxotremorine.
    Leslie GB; Hayman DG; Ireson JD; Smith S
    Arch Int Pharmacodyn Ther; 1972 May; 197(1):108-11. PubMed ID: 4402325
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental research on the action of beta-adrenergic receptor blocking agents].
    Valora N; Fidanza A; Floridi S
    Arch Fisiol; 1969 Dec; 67(3):251-72. PubMed ID: 4394262
    [No Abstract]   [Full Text] [Related]  

  • 13. The action of beta-adrenergic blocking and stimulating agents on insulin secretion. Characterization of the type of beta receptor.
    Loubatières A; Mariani MM; Sorel G; Savi L
    Diabetologia; 1971 Jun; 7(3):127-32. PubMed ID: 4397807
    [No Abstract]   [Full Text] [Related]  

  • 14. Steric aspects of adrenergic drugs. XI. Interactions of dibenamine and beta adrenergic blockers.
    Patil PN; Tye A; May C; Hetey S; Miyagi S
    J Pharmacol Exp Ther; 1968 Oct; 163(2):309-19. PubMed ID: 4386625
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pindolol. New beta blocking agent. Effect on cardiac chronotropism and ionotropism and comparison of its activity with propranolol].
    Aquaro G; Baduini G; Pavia M; Poletti T
    Minerva Cardioangiol; 1972 Jun; 20(6):324-9. PubMed ID: 4402731
    [No Abstract]   [Full Text] [Related]  

  • 16. The haemodynamic effects of ( )-propranolol, dexpropranolol, oxprenolol, practolol and sotalol in anaesthetised dogs.
    Fitzgerald JD; Wale JL; Austin M
    Eur J Pharmacol; 1972 Jan; 17(1):123-34. PubMed ID: 4401429
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of alprenolol, bunolol and propranolol on pulmonary resistance in the anaesthetized dog.
    Giles RE; Finkel MP
    Eur J Pharmacol; 1971 Oct; 16(2):155-63. PubMed ID: 4405779
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of bundle of His potentials to assess changes in atrioventricular conduction produced by a series of beta-adrenergic blocking agents.
    Smithen CS; Balcon R; Sowton E
    Br Heart J; 1971 Nov; 33(6):955-61. PubMed ID: 4399190
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardiovascular effects of alprenolol(beta-blockade) under halothane anesthesia].
    Yoshida T; Kubota M; Tamura A; Suzuki K; Furukawa Y
    Masui; 1969 Nov; 18(11):1071-8. PubMed ID: 4391283
    [No Abstract]   [Full Text] [Related]  

  • 20. A potent beta-adrenoreceptor blocking drug: 4-(2-hydroxy-3-isopropylaminopropoxy)indole.
    Moore GE; O'Donnell SR
    J Pharm Pharmacol; 1970 Mar; 22(3):180-8. PubMed ID: 4399485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.